In this sense, several studies have demonstrated that the presence of cDC1 in neoplasms is associated with a favorable prognosis [11], thus predicting the clinical outcome of melanoma patients and breast cancer [39,52]. This evidence concerns the gene MPPE1 and neoplasm.